mRNA 2416

Drug Profile

mRNA 2416

Alternative Names: mRNA-2416; OX40L mRNA - Moderna Therpeutics

Latest Information Update: 21 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Moderna Therapeutics
  • Class RNA
  • Mechanism of Action OX40 ligand modulators; OX40 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Lymphoma; Solid tumours

Most Recent Events

  • 14 Sep 2017 Phase-I clinical trials in Lymphoma in USA (Intratumoural)
  • 12 Sep 2017 Phase-I clinical trials in Solid tumours in USA (Intratumoural)
  • 01 Apr 2017 Preclinical trials in Cancer in USA (Intratumoural) before April 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top